Evidence map›Paper›PMID 40671362›Full record

ArticleAllergy2025

Delays and Barriers Related to the Treatment of Hereditary Angioedema Attacks in Italy.

Mauro Cancian, Pietro Accardo, Francesco Arcoleo, Francesco Giardino, Stefania Nicola, Riccardo Senter, Paola Triggianese, Sherry Danese, Julie Ulloa, Vibha Desai and 4 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Allergy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Impact of injectable HAE on-demand treatments on health-related quality of life: a patient and caregiver interview study.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Mauro CancianAzienda Ospedale Università di Padova, Padova, Italy.ORCID https://orcid.org/0000-0003-2246-9144
Pietro AccardoA.O. "Ospedali Riuniti Villa Sofia-Cervello"-Presidio Ospedaliero Cervello, Palermo, Italy.
Francesco ArcoleoA.O. "Ospedali Riuniti Villa Sofia-Cervello"-Presidio Ospedaliero Cervello, Palermo, Italy.
Francesco GiardinoA.O.U. Policlinico "G.Rodolico-San Marco", Catania, Italy.ORCID https://orcid.org/0009-0001-5018-5133
Stefania NicolaAllergy and Immunology Unit-AO Ordine Mauriziano di Torino and Department of Medical Sciences, University of Turin, Turin, Italy.ORCID https://orcid.org/0000-0002-9955-194X
Riccardo SenterAzienda Ospedale Università di Padova, Padova, Italy.ORCID https://orcid.org/0000-0001-7987-8235
Paola TriggianeseDepartment of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.
Sherry DaneseOutcomes Insights, Agoura Hills, California, USA.
Julie UlloaOutcomes Insights, Agoura Hills, California, USA.
Vibha DesaiKalVista Pharmaceuticals, Cambridge, Massachusetts, USA.
Joao P FradeKalVista Pharmaceuticals, Cambridge, Massachusetts, USA.
Paul K AudhyaKalVista Pharmaceuticals, Cambridge, Massachusetts, USA.
Andrea ZanichelliOperative Unit of Medicine, Angioedema Center, IRCCS Policlinico San Donato Milanese, Milan, Italy.
ITACA Group

Funding

This study was funded by KalVista Pharmaceuticals.
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

hereditary angioedemaITACAon‐demand treatmenttreatment barrierstreatment delay

Identifiers

PMID40671362
PMCPMC12590309

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.